Ameritas Investment Partners, Inc. Vigil Neuroscience, Inc. Put Options Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding VIGL
# of Institutions
54Shares Held
28MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$16.1 Million1.62% of portfolio
-
Northpond Ventures, LLC4.21MShares$11.6 Million51.65% of portfolio
-
Siren, L.L.C. New York, NY1.99MShares$5.48 Million0.15% of portfolio
-
Bvf Inc San Francisco, CA1.81MShares$4.99 Million0.11% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.51MShares$4.14 Million0.0% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $77.7M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...